Bioprocess Development and Bioreactor Scale-Up for the Production of Recombinant Lentiviral Viral Vectors in HEK293 Suspension Cell Culture
Therapeutic applications of viral vectors that initially targeted rare monogenic diseases have now grown to a broader set of indications including cell and gene therapy applications and vaccines. This has prompted the need to increase biomanufacturing capacities, which will require adjustments in th...
Guardado en:
| Autores principales: | , , , |
|---|---|
| Formato: | Capítulo de libro |
| Lenguaje: | inglés |
| Publicado: |
IntechOpen
2024
|
| Materias: | |
| Acceso en línea: | https://www.intechopen.com/chapters/88841 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares: Bioprocess Development and Bioreactor Scale-Up for the Production of Recombinant Lentiviral Viral Vectors in HEK293 Suspension Cell Culture
- Environmentally Friendly Low-Temperature Synthesis of Black TiO2 Nanoparticles and Preliminary Cytotoxicity Evaluation in HEK-293T Cells
- Lentiviral Vectors in Immunotherapy
- Designing Lentiviral Gene Vectors
- Gene Regulatable Lentiviral Vector System
- Lentiviral Gene Therapy Vectors: Challenges and Future Directions
- Targeted Lentiviral Vectors: Current Applications and Future Potential